Clinical targets for continuous glucose monitoring usually aim for at least 70% of readings in 70–180 mg/dL, with very little time low or high.
Continuous glucose monitoring (CGM) turns raw glucose traces into patterns that can guide daily diabetes care. Clinical targets for continuous glucose monitoring give that stream of numbers structure, so you and your diabetes team can see whether treatment is on track and where the main problems sit.
Instead of only chasing a single A1C value, CGM clinical targets bring in time in range, time below range, and time above range. These markers link strongly with risks such as hypoglycemia, microvascular complications, and overall glucose stability across the day.
This article walks through the main clinical targets for continuous glucose monitoring, how they came from an international consensus, and how those targets adjust for different life stages and clinical situations. You will also see practical ways to read a CGM report and use those targets without getting lost in the data.
Why Clinical Targets For Continuous Glucose Monitoring Matter
The international consensus on time in range brought together diabetes clinicians, researchers, and professional bodies to create shared CGM targets that work in both clinics and studies. Those experts linked specific time in range levels with complication risk and showed that even small gains can help over time.
For many adults with type 1 or type 2 diabetes, that consensus set a core target range of 70–180 mg/dL (3.9–10.0 mmol/L) and recommended spending at least 70% of the day inside that band. Each extra 5% in time in range appears to offer a real health benefit over the long term, especially for microvascular outcomes such as retinopathy and nephropathy.
The same group also set limits for time below range and time above range. These cutoffs help teams balance A1C and time in range against the immediate danger of hypoglycemia and the long-term burden of hyperglycemia. In short, clinical targets for continuous glucose monitoring turn a noisy trace into a summary that lines up with real-world risk.
Core Time In Range Targets For Most Adults
Clinical targets for continuous glucose monitoring start with adults who have type 1 or type 2 diabetes and are not pregnant. For this group, the consensus report and later guidance from bodies such as the American Diabetes Association set out standard CGM metrics and preferred ranges.
Standard Cgm Metrics And Preferred Ranges
Most CGM reports now show a shared set of metrics. The table below summarizes typical clinical targets for a non-pregnant adult, based on the international consensus on time in range and aligned guidance.
| CGM Metric | Standard Target Range | Typical Goal For Most Adults |
|---|---|---|
| Time in range (TIR) | 70–180 mg/dL | >= 70% of readings (about 17 hours per day) |
| Time below range (TBR) | < 70 mg/dL | < 4% of readings (under 1 hour per day) |
| Time in very low range | < 54 mg/dL | < 1% of readings (under 15 minutes per day) |
| Time above range (TAR) | > 180 mg/dL | < 25% of readings (under 6 hours per day) |
| Time in very high range | > 250 mg/dL | < 5% of readings (under 1 hour 15 minutes per day) |
| Mean glucose | Linked with A1C goal | Often matches an A1C near 7% when TIR >= 70% |
| Data coverage | At least 14 days of wear | >= 70% of possible readings captured |
These CGM goals often line up with an A1C near 7% for many adults, while still trying to keep hypoglycemia low. In daily practice, teams may stretch or relax these ranges, but the original table from the consensus report gives a clear reference point for shared decision-making.
Public resources also echo these targets. For instance, the American Diabetes Association describes time in range as the percentage of readings within 70–180 mg/dL and notes that many people with type 1 or type 2 diabetes should aim for TIR at or above 70%, with less than 4% of readings below 70 mg/dL. You can read more in the ADA’s CGM and time in range guidance.
How Time In Range Relates To A1c
Many people still view A1C as the main marker of glucose control, and it remains a central clinical measure. Time in range does not replace A1C, but it fills in gaps by showing daily swings and the share of readings that stay near the target zone.
A person with an A1C near 7% could have very different time in range profiles. One person may hover slightly high and rarely dip low. Another might bounce between frequent lows and highs, which creates far more stress day to day. Clinical targets for continuous glucose monitoring help reveal those patterns and support treatment changes that smooth the curve while keeping the A1C goal in sight.
Clinical Targets For Continuous Glucose Monitoring In Special Groups
While the table above covers many adults, some groups need adjusted CGM targets. Age, pregnancy, comorbidities, and risk of hypoglycemia all shape the best balance between time in range and safety. The international consensus and follow-up guidance give separate bands and goals for these groups.
Older Or High-Risk Adults
Older adults and people with a history of severe hypoglycemia may need more relaxed upper targets and tighter limits for time below range. For some in this group, a TIR around 50% or more in 70–180 mg/dL may be reasonable, with a strong focus on keeping time below 70 mg/dL close to zero.
Guidance often suggests less than 1% of readings below 70 mg/dL for frail adults or those with major comorbidities, even if that means accepting more readings above 180 mg/dL. The priority is to avoid lows that can lead to falls, cognitive events, or hospital visits.
Children And Adolescents
For children and adolescents with type 1 diabetes, tools and targets need to match growth, school schedules, and varying activity. The consensus report recommends a target range of 70–180 mg/dL with time in range at or above 70% where feasible. Safety around hypoglycemia remains very important, so teams often aim for time below 70 mg/dL under 4% and time below 54 mg/dL under 1%, similar to adults, while also watching overnight patterns closely.
Daily life can make these goals tough during certain phases, such as puberty or early adolescence, so clinicians often adjust targets over time rather than hold a single rigid line.
Pregnancy And Cgm Targets
Pregnancy brings tighter glucose targets to reduce risks for both the parent and the baby. For pregnant individuals with type 1 diabetes using CGM, expert groups recommend a lower target band, often 63–140 mg/dL, with more than 70% of readings in that range when this can be reached safely. Time above 180 mg/dL and time below 63 mg/dL should stay as low as possible without triggering more hypoglycemia.
Pregnancy also highlights how often CGM targets need personal adjustment, since insulin requirements shift across trimesters and overnight variation can change quickly.
Overview Of Targets Across Populations
The table below compares common CGM targets for several groups. These are sample ranges drawn from consensus documents and do not replace individual care plans.
| Population | Target Range (mg/dL) | Typical TIR Goal |
|---|---|---|
| Non-pregnant adults with T1D or T2D | 70–180 | >= 70% in range; TBR < 4%, < 1% < 54 mg/dL |
| Older or high-risk adults | 70–180 (often wider in practice) | Around 50% or higher TIR; TBR as close to 0% as possible |
| Children and adolescents with T1D | 70–180 | >= 70% TIR where feasible; standard TBR limits |
| Pregnancy with T1D | 63–140 | >= 70% TIR; minimal time above 160–180 mg/dL |
| Pregnancy with T2D or GDM | Similar to T1D pregnancy, adjusted case by case | High TIR with very little hypoglycemia |
| Advanced comorbidities or limited life expectancy | Often wider bands such as 80–200 | Lower TBR takes priority; TIR goals relaxed |
| New CGM users | 70–180 | Gradual move toward consensus TIR targets over time |
How To Read A Cgm Report In Practice
Most modern CGM platforms summarise clinical targets on a single page, often called an ambulatory glucose profile (AGP). At the top you will usually see time in range, time below range, and time above range, followed by a central graph that shows median glucose and the spread across the day.
Start by looking at TIR and the shares of time below and above range for the full period, often 14 days. Next, scan the AGP graph for blocks of the day where the curve runs high or low, such as early morning, overnight, or after evening meals. Short windows with steep drops or spikes tell you where treatment changes might have the biggest effect.
Patterns That Point Toward Action
Several patterns come up again and again in CGM reports:
- Overnight lows that pull TBR above target, often linked with basal insulin dose or timing.
- Post-meal spikes that push time above range up, which may relate to meal size, insulin timing, or missed boluses.
- Wide swings after exercise, where glucose rises or falls sharply for several hours.
- Persistent late-afternoon highs, which might reflect waning basal action or regular snacks.
Clinical targets for continuous glucose monitoring help you and your team rank these issues. A modest post-meal rise that still keeps TIR above 70% may need less attention than overnight lows that raise TBR above the threshold.
When And How To Set Individualized Cgm Targets
Consensus targets give a starting point, not a fixed rule for every person. Real-world plans adjust those targets in light of age, duration of diabetes, hypoglycemia history, comorbidities, pregnancy status, and treatment type.
Some people may need a period with more permissive targets while a new therapy starts, during steroid courses, or around major illness. Others, such as those planning pregnancy or recovering from an acute event, may benefit from tighter time in range goals for a limited season, with close follow-up.
Any change in clinical targets for continuous glucose monitoring should come from shared discussion between the person living with diabetes and the care team. That conversation can weigh the pressure of intensive targets against quality of life, work patterns, and stress around alarms.
Practical Tips To Improve Time In Range Safely
Once the targets are set, day-to-day habits make the difference. CGM data can feel overwhelming, so small, specific steps often work best.
Everyday Moves That Help TIR
- Check CGM trend arrows before meals and at set times in the day so you know whether glucose is climbing, steady, or falling.
- Match bolus timing with meal content; many people see better post-meal TIR when rapid-acting insulin goes in 10–20 minutes before eating, unless glucose is already low.
- Use CGM alerts thoughtfully; set low alerts high enough to warn early but not so high that alarms sound all day.
- Review patterns once every week or two rather than chasing every swing; adjust one factor at a time, such as breakfast ratio or basal dose timing.
- Note days with illness, heavy exercise, or unusual meals in the CGM app so your team can interpret outlier traces.
These steps align with the clinical targets for continuous glucose monitoring by nudging time in range upward without adding much risk of hypoglycemia.
When To Talk To Your Care Team About Cgm Data
CGM targets and patterns should always feed back into shared care. Bring printed or digital AGP reports to visits, and point out the times of day that worry you most. Ask how your current TIR, TBR, and TAR compare with the targets your team feels are realistic for your situation.
If you see TBR above the suggested limits, frequent readings below 70 mg/dL, or time in very low range, raise that early. Sudden shifts in TIR, such as a drop from around 70% to under 50% without a clear cause, also deserve a prompt review. CGM offers rich detail, but those numbers work best when paired with clinical judgement and your own experience of daily life.
This article provides general information about clinical targets for continuous glucose monitoring and does not replace personal medical advice from your own diabetes clinician or care team. Any changes to medication, insulin doses, or CGM settings should be made together with a qualified professional who knows your history.